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ABSTRACT We present genetic evidence for complex for-
mation of STE5 and the STEll, STE7, and FUS3 protein
kn , the pheromone-responsive mitogen-activated protein
kinase module of Saccharomyces cerevisiae. Interaction be-
tween STE5 and STEll is not dependent on STE7, and
interaction between STE5 and STE7 does not require STEMl.
The N-terminal regulatory domain of STEll is both neceary
and sufficient for interaction with STE5. Interaction between
STE7 and STEll is bridged by STE5, suggesting the formation
of a multiprotein complex. We also demonstrate biochemical
interaction between STE5 and STEll by using a combination
of bacterially expressed fusion proteins and extracts prepared
from yeast. Our results suggest that STE5 is a scaffolding
protein that facilitates interactions between components of the
pheromone-responsive mitogen-activated protein kinase mod-
ule. We further propose that such scaffolding proteins serve to
inhibit cross-talk between functionally unrelated mitogen-
activated protein kinase modules within the same cell.
Signaling between a and a haploid cells of the yeast Saccha-
romyces cerevisiae is mediated by the reciprocal action of
secreted peptide pheromones, termed a factor and a factor,
respectively (1, 2). These mating pheromones bind to seven-
transmembrane-domain receptors, encoded by the STE2 and
STE3 genes (3-5), that signal through a heterotrimeric gua-
nine nucleotide binding protein (G protein). The Gsy subunits
of the G protein, encoded by the STE4 and STE18 genes,
respectively, transduce the pheromone signal to downstream
components, and the Ga subunit, encoded by the GPAI/
SCGJ gene, acts as a negative control element (6-8). A group
of protein kinases, which we refer to as a mitogen-activated
protein kinase (MAP kinase) module (9, 10), functions down-
stream of the G protein (11-14). This pheromone-responsive
module is composed of the STEMJ, STE7, and FUS3/KSSJ
gene products. MAP kinase modules are highly conserved in
eukaryotic organisms: FUS3 and KSS1 are structurally re-
lated to metazoan MAP/ERK kinases (15); STE7 is struc-
turally related to MAP kinase activators, variously referred
to as MAP kinase kinases and MEKs (16, 17); and STE11 is
structurally related to the mammal MEK kinase (MEKK),
a MAP kinase kinase activator (18). In addition, we have
shown that STE11, STE7, and FUS3/KSS1 are structurally
and functionally related to the respective byr2, byrl, and
spkl protein kinases of the evolutionarily distant yeast
Schizosaccharomyces pombe (10).
Recent genetic studies using hyperactive mutant alleles of
the STE5 and STEJJ genes suggest that the product encoded
by the STES gene functions at a level between the mating
pheromone receptor-coupled G protein and the MAP kinase
module in Sa. cerevisiae (11, 13, 19). The predicted sequence
of the STE5 gene product does not contain structural motifs
that immediately suggest a catalytic function (20, 21). There-
fore, as a first step toward the functional characterization of
the STE5 protein, we have utilized a genetic method, the
yeast two-hybrid system (22), to detect physical interactions
between STE5 and components of the Sa. cerevisiae pher-
omone response pathway. In this report, we show that STE5
forms complexes with the STE7, STEll, and FUS3 protein
kinases. We also provide evidence that STE5 is required for
efficient in vivo interaction between STE7 and STE11, two
proteins that have been shown to interact in vitro (23). These
and additional results described herein lead us to propose that
STE5 may function as a molecular scaffold that is required for
the proper activity of the Sa. cerevisiae pheromone-
responsive MAP kinase module. Our results may be relevant
to the function and integration of MAP kinase modules in
general.
MATERIALS AND METHODS
Yeast Strains, Media, and Genetic Manipulations. Sa. cere-
visiae YPB2 [MATa ade2-101 his3-200 leu2-3,112 lys2-801
ura3-52 trpl-901 canr gal4-542 gal80-538 LYS2::GAL1uAs-
HIS3TATA-HIS3 URA3::GAL]j7mers(3x)-CYClTATA-lacZ] and
L40 (MATa ade2 his3 leu2 trpl LYS2::1exA-HIS3 URA3::
lexA-lacZ) were used as hosts for two-hybrid experiments
(24, 25). steSA (L40ST5AA), ste7A (L40ST7AA), and stellA
(L40ST11AA) derivatives ofL40 were made by one-step gene
replacement (26) using ste5A::ADE2 (from pBSSTE5A::
ADE2), ste7A::ADE2 (from pBSSTE7A::ADE2), and
stellA: :ADE2 (from pBSSTE11A: :ADE2), respectively.
Epitope-tagged fusion proteins were expressed in Sa. cere-
visiae YPH499 (MATa ade2-101c his3-A200 leu2-AJ lys2-
801am trpl-Al ura3-52) (27). AN43-5A (MATa adel arg4
leu2-3,112 trpl ura3-52 mfal::FUSJ::lacZ his3::FUSI::
HIPS), provided by A. Neiman and I. Herskowitz (University
of California, San Francisco), was used for expression of
glutathione S-transferase (GST) fusion proteins in yeast.
Yeast cultures were grown in YPD [1% yeast extract/2%
(wt/vol) peptone/2% (wt/vol) glucose] or in synthetic min-
imal (SM) medium (0.67% yeast nitrogen base/2% glucose/
appropriate auxotrophic supplements). Standard yeast ge-
netic methods were followed (28).
Nucleic Acid Manipulation and Analysis. The two-hybrid
plasmids pGADGH [for GAL4 transcriptional activation
domain (GAD) fusions], pGBT9 and pGBT10 [for GAL4
DNA binding domain (GBD) fusions], pGADHRASRl86,
pGBDRAS2R3l9, pGBDRAF, pGADbyr2, pGBDbyr2,
pGADSNF1, pGBDSNF4, and pBTM116 (for expression of
lexA fusion proteins) have been described (24, 25). pHP5
(kindly provided by H.-P. Xu, Cold Spring Harbor Labo-
ratory) is derived from pGBT10 and contains a frame shift
in the polylinker such that the BamHI frame is TCG GAT
CCC. pRD56 (29) and pRP259, a derivative of pGEX-3
Abbreviations: GAD, GAL4 transcriptional activation domain;
GBD, GAL4 DNA binding domain; LBD, lexA DNA binding do-
main; GST, glutathione S-transferase; G protein, guanine nucleotide
binding protein; MAP kinase, mitogen-activated protein kinase;
MEK, MAP kinase kinase; MEKK, MEK kinase.
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(Pharmacia), were used for expression of GST fusion
proteins in yeast and bacteria, respectively. Polymerase
chain reactions (PCRs) were used to generate fragments of
the STE5, STEll, STEllAC (encoding residues 1-415),
STEllAN (encoding residues 416-717), STE7, FUS3, byrl,
spkl, MEK, and MEKK coding sequences compatible for
cloning into GAD, GBD, and lexA two-hybrid expression
vectors and/or into epitope-tagged or GST fusion protein
expression vectors. pBSSTE5A::ADE2 was constructed by
cloning a Kpn I-BamHI fragment of the STE5 gene (from
pSL1420, provided by B. Stevenson and G. Sprague, Univer-
sity of Oregon, Eugene) into the corresponding sites of pB-
luescript II SK- (Stratagene) and then replacing an EcoRI-
Xho I fragment of the STES sequence with a 2.3-kb fragment
oftheADE2 gene (from pASZ11; ref. 30). pBSSTE11A::ADE2
was constructed by cloning a Kpn I-Xba I fragment ofSTEIJ
(from pSL1507, provided by B. Stevenson and G. Sprague)
into the corresponding sites of pBluescript II SK- and then
replacing the HindIII fragment of the gene with ADE2.
pBSSTE7A::ADE2 was constructed by cloning a HindIII
fragment ofSTE7 (from pJD7, provided by Stan Fields, State
University of New York, Stony Brook) into the BamHI-Sal
I sites of pUC119 and then replacing the Msc I-Bgl II
fragment of the gene with ADE2. pAUD6STE5 contains a
PCR fragment ofSTE5 cloned into theBamHI site ofpAUD6
(kindly provided by R. Ballester, University of California,
Santa Barbara), which is derived from pRS423 (27). This
plasmid provides for expression of a N-terminal c-myc epi-
tope (31) fused to STESprotein from the Sa. cerevisiaeADHl
promoter. pAAUD6STE5 was constructed by cloning an
ADE2 gene fragment into the Sac I site 3' of the STE5 insert
in pAUD6STE5. pAD5STE11 was constructed by cloning a
PCR fragment of the STE11 coding sequence into pAD5 (10),
which allows for expression of a N-terminal hemagglutiin
epitope-tagged (32) STEll protein in yeast.
I3Galactosidase Filter Assay. The filter assay for testing
two-hybrid interactions was performed as described (24). We
conducted lexA two-hybrid experiments with lexA DNA
binding domain (LBD) and GAD pairs of fusion proteins.
Preparation of Yeast and Bacterial Lysates, Isolation ofGST
and Immune Complexes, and in Vitro Binding Studies. Yeast
cultures expressing epitope-tagged and GST fusion proteins
were grown in SM and SMGal medium [SM without glucose
and containing 2% (wt/vol) galactose, 2% (vol/vol) glycerol,
and 1% ethanol], respectively, at 30°C to 2 x 107 cells per ml,
and lysates were prepared as described (33). Escherichia coli
BL21, transformed with GST, GSTSTE5, or GSTSTE11AC
fusion protein expression plasmids, was grown in LB with
amnpicillin at 100 pg/ml (LBAmp) at 37°C to stationary phase,
and then diluted 1:100 into fresh LBAmp and grown an
additional 2 hr at 37°C, at which time isopropyl j-D-
thiogalactopyranoside was added to 0.1 mM. After an addi-
tional 4-hr incubation at 37°C, lysates were prepared as
described (34). GST fusion proteins were purified from yeast
and bacterial lysates as described (23, 34). GST fusion
protein-bound glutathione-agarose beads were mixed with
500 ,ug of yeast cell lysate, and lysis buffer was added so that
the total volume was 500 p1. The resulting slurry was incu-
bated at 4°C for 2 hr and then washed three times with lysis
buffer (33). Samples were resolved by SDS/PAGE in 10%
gels and then transferred to nitrocellulose (Schleicher &
Schuell). Epitope-tagged proteins were detected by immu-
noblot analysis with a 1:10,000 dilution of ascites fluid
containing monoclonal antibody 12CA5, for hemagglutinin
epitope-tagged proteins (32), or 9E10, for c-myc epitope-
tagged proteins (31), followed by detection using the ECL
chemiluminescent kit (Amersham).
RESULTS
Genetic Evidence for Complex Formation Between STE5
and the STEll, STE7, and FUS3 Protein Kinases. We
utilized the yeast two-hybrid system (22) to examine
whether STE5 interacts physically with components of the
pheromone-responsive MAP kinase module. Interactions
between numerous proteins havebeen demonstrated using
the two-hybrid system. We (24) and others (25) have used
the system to show interactions between RAS and RAF
oncoproteins, between RAS and the Sc. pombe byr2 protein
kinase (24), and between RAF and MEK (24). A summary
of the pairwise protein interactions tested in this study is
presented in Table 1.
To test whether STE5 and STE11 form a complex, we
constructed vectors to express STE5 or STE11 fused to GBD
or to GAD in the tester strain, YPB2. As shown in Fig. 1A,
interaction between STE5 and STE11 was detected, based on
f-galactosidase production resulting from induction of
GALJ-lacZ by either GADSTE5 and GBDSTE11 or by
GADSTE11 and GBDSTE5. Neither STE5 nor STE11 fusion
proteins interacted with GADSNF1 or GBDSNF4 fusion
proteins (22, 35), which were used as controls (Fig. 1). The
STE11 kinase is composed of an N-terminal regulatory
domain (approximately residues 1-415) and a C-terminal
catalytic domain (approximately residues 416-717) (11). As
Table 1. Pairwise combinations of GBD, LBD, and GAD fusion proteins tested in this study
8-Galactosidase induction
DI'un >
GAD uiDJJ 1U1Uio LDLP lUsion
fusion STE5 STEll STEllAC STEllAN STE7 FUS3 byr2 byrl RAF RAS2R319 SNF4 STEll STE7 byr2 MEK HRASR186
STE5 - + + - + - - - - - - + + - - -
STE7 + - - + . . + .
STE11 + + - - - - + + -
STE11AC + . . . . . _ . .
FUS3 + - + _ - + + .
byr2 - +
spkl - + .
MEKK - *
MEK - + .
HRASRl86 + + +
RAF * * + +
SNF1 - - - - - - _ _ _ _ + .
Values represent the presence of transformed colonies that expressed detectable &galactosidase activity (+) or not (-). , Not determined.
The proteins to left of the table were fused to GAD. The proteins at the top of the table were fused to either GBD or LBD. GBD-GAD
combinations were expressed in the GAL4 two-hybrid tester strain, YPB2. LBD-GAD combinations were tested in the lexA tester strain, L40.
At least four transformants were tested for each determination.
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FIG. 1. STE5 forms complexes with components of the pheromone-responsive MAP kinase module. STE5, STEll, STE11AC (residues
1-415), STEllAN (residues 416-717), STE7, and FUS3 fused to either GBD or GAD were tested for interaction by their induction of
P-galactosidase expression (darker patches in the black and white photographs) in the host strain YPB2 (A-C). Each patch represents an
independent transformant. Sa. cerevisiae SNF1 and SNF4 were used as positive controls. (A) STE5 forms a complex with the STE11 protein
kinase. (B) N-terminal regulatory domain ofSTE11 is both necessary and sufficient for complex formation with STES. (C) STE5 forms complexes
with the STE7 and FUS3 protein kinases. (D) STES and STE11 form a complex in vitro. GSTSTE5 and GSTSTE11AC fusion proteins were
purified from bacterial lysates and GSTSTE11 fusion protein was purified from yeast lysates. GST or GST fusion proteins bound to
glutathione-agarose beads were mixed with lysates prepared from yeast strains expressing (+) or not (-) either c-myc epitope-tagged STE5
(MSTE5) or hemagglutinin epitope-tagged STE11 (HASTE11) proteins. After a 2-hr incubation at 40C, the unbound fraction (one-thirtieth of
the total volume) was sampled, mixed with SDS sample buffer, and boiled for 5 min. The beads containing bound fractions were washed,
resuspended in a small volume of SDS sample buffer, and boiled for 5 min. Bound (one-third of the resuspended slurry) and unbound samples
were electrophoresed in 10%6 polyacrylamide gels, and proteins were transferred to nitrocellulose. Monoclonal antibody 9E10 was used to detect
MSTE5 protein (left side ofpanel) bound to beads, and monoclonal antibody 12CA5 was used to detect HASTE11 (right side ofpanel). Bacterially
expressedGSTSTE11AC and yeast-expressed GSTSTE11 fusion proteins were each capable ofbinding to MSTE5 expressed in yeast. Bacterially
expressed GSTSTE5 was capable of binding to HASTE11 expressed in yeast. Neither MSTE5 or HASTE11 proteins could bind to the GST
moiety alone.
shown in Fig. 1B, the N terminus of STE11 was both
necessary and sufficient for interaction with STE5.
We next examined whether STE5 interacts with other
components ofthe MAP kinase module. As shown in Fig. 1C,
STE5 also interacted with both the STE7 and FUS3 protein
kinases. Recent studies have demonstrated that FUS3 func-
tions downstream of STE7 and STEll (23, 36). In addition,
while our manuscript was in preparation, other investigators
(37) reported independently on complex formation between
STE5 and FUS3. These workers also showed that STE5 is
phosphorylated by FUS3. In this report, we describe exper-
iments that focus primarily on the interactions of STE5,
STE7, and STEll.
Biochemical Evidence for Complex Formation Between STE5
and STEMl. To obtain biochemical evidence for complex
formation between STE5 and STEll, we utilized GST fusion
proteins purified from bacteria or yeast and extracts prepared
from yeast expressing epitope-tagged proteins (32). STE5 and
STEllAC were expressed as GST fusion proteins in bacteria,
and full-length STEll was expressed as a GST fusion protein
in yeast. GST fusion proteins purified from bacterial or yeast
lysates were mixed with lysates prepared from yeast strains
that expressed either the c-myc epitope-tagged STE5
(MSTE5) or the hemagglutinin epitope-tagged STEll(HASTEll) proteins. As shown in Fig. 1D, bacterially ex-
pressed GSTSTE5 was capable of binding to HASTE11 ex-
pressed in yeast. GSTSTE11 and GSTSTE11AC, purified
from yeast and bacteria, respectively, were each capable of
binding to MSTE5 expressed in yeast. These results confirm
the interaction detected between STE5 and STEll in the
two-hybrid system.
STE5 Is Required for Strong Interaction Between STEll and
STE7. Other investigators have shown that the STEll protein
kinase is required for pheromone-induced hyperphosphory-
lation of STE7 in vivo (14). In addition, Neiman and Her-
skowitz (23) have recently demonstrated that STE7 is phos-
phorylated and activated by STEll in vitro using proteins
isolated from yeast. We therefore tested whether interaction
between STE7 and STEll could be detected in the two-
hybrid system. Unassisted, STE7 and STEll failed to form
a detectable complex using the GAD and GBD vectors in our
host strain, YPB2 (Fig. 2A). However, because STE5 inter-
acts with both STE7 and STEll, we examined whether the
three proteins might form a complex. Indeed, when STE5
was overexpressed, interaction between STE7 and STEll
was detected. Furthermore, the N-terminal regulatory do-
main of STEll was sufficient for STE5-promoted complex
formation with STE7 (Fig. 2B). These results suggested that
STE5, STE7, and STEll form a multiprotein complex. To
examine this possibility further, we made use of the lexA-
based two-hybrid system, which is similar to the GAL4-based
system but utilizes the bacterial LBD in combination with an
acidic activation domain to drive transcription from a lexA-
lacZ reporter gene (25). We have found this system in some
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FIG. 2. Evidence that STE5, STE7, and STE11 form a multiprotein complex. The GAL4 two-hybrid tester strain, YPB2, was transformed
(+) or not (-) with plasmids expressing STE7 fused to GBD, STEll or STEllAC fused to GAD, and/orMSTE5 and assayed for P-galactosidase
expression (shown to the right of A and B). Complex formation between STEll and STE7 in the GAL4-based two-hybrid system requires
overexpression of STE5 (A). The N-terminal regulatory domain of STEll is sufficient for multiprotein complex formation with STE5 and STE7
(B). Complex formation among STE5, STE7, and STEll in the lexA-based two-hybrid system is shown in C. STE5, STEll, and STE7 fused
to LBD orGAD were tested for interaction by their induction of P-galactosidase expression in the lexA two-hybrid tester strain LAO or in strains
derived from L40 carrying deletions ofSTES, STE7, or STE)) genes, as indicated. In the more-sensitive lexA-based system, interaction between
STEll and STE7 does not require overexpression of STE5. However, the interaction between these kinases is significantly reduced in a steSA
mutant. Interaction between STE5 and STE7 in the lexA system is not dependent on STEll, and interaction between STE5 and STEll does
not require STE7.
cases, when using the tester strains described above, to be
more sensitive than the GAL4-based system. Using the lexA
two-hybrid system, we were able to detect interaction be-
tween STE7 and STEll fusion proteins (Table 1). We also
detected interactions between STE5 and STEll and between
STE5 and STE7 as was observed in the GALA-based system.
We next examined pairwise interactions of STE5, STE7,
and STEll in various Sa. cerevisiae deletion mutants derived
from the lexA two-hybrid tester strain, L40. Deletion of the
STE7 gene did not markedly affect the interaction between
STE5 and STEll, and interaction between STE5 and STE7
was not affected by deletion of the STEJJ gene (Fig. 2B).
However, compared to the interaction detected in a wild-type
(STE5+) strain, the interaction between STE7 and STEll was
significantly reduced in a steS null mutant. In addition, we
observed a stronger interaction between STE7 and STEll
fusion proteins when STE5 was overexpressed from a third
plasmid than was observed in cells expressing wild-type
levels of STE5 (data not shown). These results suggest a role
for STE5 in facilitating interaction between STE7 and STEll.
Additional Interactions Between MAP Kinase Module Com-
ponents. We used the two-hybrid system to detect additional
interactions between components of the pheromone-
responsive MAP kinase module. Interaction between
LEXSTE7 and GADSTE7 was detected, as was interaction
between LEXSTE11 and GADSTE11 (Table 1), consistent
with the observations of other investigators that STE7 and
STEll protein kinases autophosphorylate in vitro (23, 36).
Formation of STE7 or STE11 complexes was unaffected by
deletion of the STE5 gene (data not shown). Errede et al. (36)
have provided evidence that STE7 protein kinase purified
from yeast extracts phosphorylates and activates FUS3 ki-
nase purified from a bacterial expression system. Consistent
with their observations, we detected interaction between
STE7 and FUS3 (Table 1). These interactions were main-
tained even in strains carrying deletions ofthe STE5 or STE]I
genes (data not shown). We also detected interaction be-
tween STE11 and FUS3 in the two-hybrid system (Table 1).
Interaction between these two kinases was maintained in
strains carrying deletions of STE5 or STE7 (data not shown).
STES Does Not Interact with the Sc. pombe byrl or byr2
Protein Kinases or with the Mammalian MEK, MEKK, or
RAF Kinases. As shown in Table 1, we did not detect
interactions between STE5 and the Sc. pombe homologs of
STE7 and STEll, byrl or byr2, respectively, suggesting that
determinants required for interaction with STE5 have not
been conserved in the Sc. pombe kinases. STE5 also failed to
interact with the mammalian MEK and MEKK, which are
structurally related to STE7 and STEll, respectively. Inter-
estingly, interactions between byrl and byr2 (M.B., unpub-
lished results) or between MEK and MEKK (Table 1) were
not detected even when STE5 was overexpressed. We also
failed to detect complex formation between STE5 and the
mammalian RAF protein kinase (Table 1), a MAP kinase
kinase activator that is not related structurally to either
MEKK or STEll (38-40).
DISCUSSION
Previous studies suggested that STE5 functions at a level
between the mating pheromone receptor-coupled G protein
and the pheromone-responsive MAP kinase module in Sa.
cerevisiae. We have used the yeast two-hybrid system to
show that STE5 forms complexes with the STEll, STE7, and
FUS3 protein kinases that compose the pheromone-
responsive MAP kinase module. Sa. cerevisiae strains car-
rying ste7 or stelI null mutations were used to show that the
interaction detected between STE5 and STEll was not
bridged by STE7 and that the interaction between STE5 and
STE7 was not bridged by STEll. However, interaction
between STE7 and STEll in the two-hybrid system was
bridged by STE5. In addition to genetic experiments, we used
a combination of epitope-tagged and GST fusion proteins to
obtain biochemical evidence for complex formation between
STE5 and STEll. In an independent study, Choi et al. (41)
have also demonstrated complex formation between STE5
and the pheromone-responsive MAP kinase module.
Our results suggest possible functions for STES. One
function of STE5 may be to directly modulate STEll activ-
ity, since it is the N-terminal regulatory domain of STEll
with which STE5 interacts. Another is that STE5 functions as
a molecular scaffold that promotes and/or modulates inter-
action between STE7 and STEll by interacting directly with
both proteins. Alternatively, the dependence on STE5 for
interaction between STE7 and STE11 may result from a
STE7
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STE1 1 [
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requirement that STEll be modified in a STE5-dependent
manner to interact with STE7. With respect to this latter
possible STE5 function, we determined that the pairwise
interactions detected among the STE5, STE7, and STEll
proteins are not dependent on either the STE4 or STE20 gene
products (S.M., unpublished observations), each of which
acts upstream of STE5 in the Sa. cerevisiae pheromone
signaling pathway, as judged by genetic analyses (19, 42).
Thus, interactions of STE5, STE7, and STEll do not require
basal signaling from either the G protein or STE20.
Besides the pheromone-responsive MAP kinase module,
two additional MAP kinase modules are involved in distinct
physiological responses in Sa. cerevisiae. One of these is
required for proper cell wall construction, and the other
mediates responses to extracellular salt concentration (for
review, see ref. 43). Given the diversity of MAP kinase
modules exemplified in yeast, it seems inevitable that an even
greater diversity will emerge from metazoans. Indeed, to date
at least four distinct MAP kinase homologs (15), three MAP
kinase kinase homologs (44, 45), and two MAP kinase kinase
kinases, RAF and MEKK (18, 38-40), have been identified in
mammals. Furthermore, recent studies suggest that MAP
kinases can be activated by multiple pathways (18, 46-48).
The existence of multiple MAP kinase modules in a single cell
presents an obvious problem-that of potential cross-talk
between functionally similar, but distinct, modules. Indeed,
we have found that the STEIJ gene, when overexpressed, can
suppress the loss of BCKI (M.B., S.M., and L. Van Aelst,
unpublished results), which encodes the protein kinase struc-
turally related to STEll that is required for proper cell wall
construction in Sa. cerevisiae (49). The existence of proteins
like STE5, required for interaction of the proper MAP kinase
module components, allows the evolution of multiple MAP
kinase modules in the same cell that can process signals
without interference. Our failure to detect interactions be-
tween Sc. pombe byrl and byr2 or between mammalian MEK
and MEKK, may reflect a requirement for proteins similar to
STE5 that facilitate interactions between these pairs ofprotein
kinases. The two-hybrid system we have used to detect
interactions between STE5 and members of the pheromone-
responsive MAP kinase module of Sa. cerevisiae may be used
to search for functional homologs of STE5 in Sc. pombe and
metazoan cDNA-GAD fusion libraries.
We thank R. Ballester, J. Cooper, I. Herskowitz, G. Johnson, E.
Leberer, A. Neiman, G. Sprague, L. Van Aelst, A. Vojtek, and H.-P.
Xu for kindly providing plasmids and yeast strains; M. Cobb, S.
Fields, I. Herskowitz, K. Marcus, and A. Neiman for helpful
comments on the manuscript; and E. Elion, A. Neiman, and I.
Herskowitz for communicating results prior to publication. We also
thank G. Asouline, M. Riggs, and L. Rodgers for technical assis-
tance. This work was supported by the American Cancer Society and
the National Cancer Institute of the National Institutes of Health.
S.M. is an American Cancer Society postdoctoral fellow. M.W. is an
American Cancer Society professor.
1. Marsh, L., Neiman, A. M. & Herkowitz, I. (1991) Annu. Rev. Cell
Biol. 7, 699-728.
2. Kurian, J. (1992) Annu. Rev. Biochem. 61, 1097-1129.
3. Burkholder, A. C. & Hartwell, L. H. (1985) Nucleic Acids Res. 13,
8463-8475.
4. Nakayama, N., Miyajima, A. & Arai, K. (1985) EMBO J. 4,
2643-2648.
5. Hagen, D. C., McCaffrey, G. & Sprague, G. F., Jr. (1986) Proc.
Nati. Acad. Sci. USA 83, 1418-1422.
6. Dietzel, C. & Kurian, J. (1987) Cell 50, 1001-1010.
7. Miyajima, I., Nakafuku, M., Nakayama, N., Brenner, C., Miya-jima, A., Kaibuchi, K., Arai, K., Kaziro, Y. & Matsumoto, K.
(1987) Cell 50, 1011-1019.
8. Whiteway, M., Hougan, L., Dignard, D., Thomas, D. Y., Bell, L.,
Saari, G. C., Grant, F. J., O'Hare, P. & MacKay, V. L. (1989) Cell
56, 467-477.
9. Marcus, S., Wigler, M., Xu, H.-P., Ballester, R., Kawamukai, M.
& Polverino, A. (1993) in The GTPase Superfamily, Ciba Founda-
tion Symposium 176, eds. Marsh, J. & Goode, J. (Wiley, Chichester,
U.K.), pp. 53-66.
10. Neiman, A. M., Stevenson, B. J., Xu, H.-P., Sprague, G. F., Jr.,
Herskowitz, I., Wigler, M. & Marcus, S. (1993) Mol. Biol. Cell 4,
107-120.
11. Cairns, B. R., Ramer, S. W. & Kornberg, R. D. (1992) Genes Dev.
6, 1305-1318.
12. Gartner, A., Nasmyth, K. & Ammerer, G. (1992) Genes Dev. 6,
1280-1292.
13. Stevenson, B. J., Rhodes, N., Errede, B. & Sprague, G. F., Jr.
(1992) Genes Dev. 6, 1293-1304.
14. Zhou, Z., Gartner, A., Cade, R., Ammerer, G. & Errede, B. (1993)
Mol. Cell. Biol. 13, 2069-2080.
15. Boulton, T. G., Nye, S. H., Robbins, D. J., Ip, N. Y., Rad-
ziejewska, E., Morgenbesser, S. D., DePinho, R. A., Panayotatos,
N., Cobb, M. H. & Yancopoulos, G. D. (1991) Cell 65, 663-675.
16. Crews, C., Alessandrini, A. & Erikson, R. (1992) Science 258,
478-480.
17. Kosako, H., Nishida, E. & Gotoh, Y. (1993) EMBO J. 12, 787-794.
18. Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer,
K. J. & Johnson, G. L. (1993) Science 260, 315-319.
19. Hasson, M. S., Blinder, D., Thorner, J. & Jenness, D. D. (1994)
Mol. Cell. Biol. 14, 1054-1065.
20. Mukai, Y., Harashima, S. & Oshima, Y. (1993) Mol. Cell. Biol. 13,
2050-2060.
21. Perlman, R., Yablonski, D., Simchen, G. & Levitzki, A. (1993)
Proc. Natl. Acad. Sci. USA 90, 5474-5478.
22. Fields, S. & Song, 0. (1989) Nature (London) 340, 245-246.
23. Neiman, A. N. & Herskowitz, I. (1994) Proc. Natl. Acad. Sci. USA
91, 3398-3402.
24. Van Aelst, L., Barr, M., Marcus, S., Polverino, A. & Wigler, M.
(1993) Proc. Natd. Acad. Sci. USA 90, 6213-6217.
25. Vojtek, A. B., Hollenberg, S. M. & Cooper, J. A. (1993) Cell 74,
205-214.
26. Rothstein, R. (1983) Methods Enzymol. 101, 202-209.
27. Sikorski, R. S. & Hieter, P. (1989) Genetics 122, 19-27.
28. Rose, M. D., Winston, F. & Hieter, P. (1990) Methods in Yeast
Genetics: A Laboratory Course Manual (Cold Spring Harbor Lab.
Press, Plainview, NY).
29. Park, H. O., Chant, J. & Herskowitz, I. (1993) Nature (London)
365, 269-274.
30. Stotz, A. & Linder, P. (1990) Gene 95, 91-98.
31. Evan, G. I., Lewis, G. K., Ramsey, G. & Bishop, J. M. (1985) Mol.
Cell. Biol. 5, 3610-3616.
32. Field, J., Nikawa, J.-I., Broek, D., MacDonald, B., Rodgers, L.,
Wilson, I. A., Lerner, R. A. & Wigler, M. W. (1988) Mol. Cell.
Biol. 8, 2159-2165.
33. Peter, M., Gartner, A., Horecka, J., Ammerer, G. & Herskowitz,
I. (1993) Cell 73, 747-760.
34. Smith, D. B. & Johnson, K. S. (1988) Gene 67, 31-40.
35. Celenza, J. L., Eng, F. J. & Carlson, M. (1989) Mol. Cell. Biol. 9,
5045-5054.
36. Errede, B., Gartner, A., Zhou, Z., Nasmyth, K. & Ammerer, G.
(1993) Nature (London) 362, 261-264.
37. Kranz, J. E., Satterberg, B. & Elion, E. A. (1994) Genes Dev. 8,
313-327.
38. Dent, P., Haser, W., Haystead, T., Vincent, L., Robert, T. &
Sturgill, T. (1992) Science 257, 1404-1407.
39. Howe, L. R., Leevers, S. J., G6mez, N., Nakielny, S., Cohen, P.
& Marshall, C. J. (1992) Cell 71, 335-342.
40. Kyriakis, J., App, H., Zhang, X.-F., Baneijee, P., Brautigan, D.,
Rapp, U. & Avruch, J. (1992) Nature (London) 358, 417-421.
41. Choi, K. Y., Satterberg, B., Lyons, D. L. & Elion, E. A. (1994)
Cell, in press.
42. Leberer, E., Dignard, D., Harcus, D., Thomas, D. Y. & Whiteway,
M. (1992) EMBO J. 11, 4815-4824.
43. Errede, B. & Levin, D. E. (1993) Curr. Opin. Cell Biol. 5,254-260.
44. Zheng, C. F. & Guan, K. L. (1993) J. Biol. Chem. 268, 11435-
11439.
45. Zheng, C. F. & Guan, K. L. (1993) J. Biol. Chem. 268, 23933-
23939.
46. Robbins, D. J., Cheng, M., Zhen, E., Vanderbilt, C. A., Feig, L. A.
& Cobb, M. H. (1992) Proc. Natl. Acad. Sci. USA 89, 6924-6928.
47. Blenis, J. (1993) Proc. Natd. Acad. Sci. USA 90, 5889-5892.
48. Crews, C. M. & Erikson, R. L. (1993) Cell 74, 215-217.
49. Lee, K. S. & Levin, D. E. (1992) Mo!. Cell. Biol. 1 172-182.
7766 Cell Biology: Marcus et al.
